JP2022528024A5 - - Google Patents
Info
- Publication number
- JP2022528024A5 JP2022528024A5 JP2021525181A JP2021525181A JP2022528024A5 JP 2022528024 A5 JP2022528024 A5 JP 2022528024A5 JP 2021525181 A JP2021525181 A JP 2021525181A JP 2021525181 A JP2021525181 A JP 2021525181A JP 2022528024 A5 JP2022528024 A5 JP 2022528024A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- tumor
- cells
- binding domain
- tag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025072427A JP2025129148A (ja) | 2018-10-30 | 2025-04-24 | Ｃａｒを発現する免疫細胞に抗原提示細胞を係合させるための二重特異性ポリペプチド及びそれらの使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018904117A AU2018904117A0 (en) | 2018-10-30 | Polypeptides and uses thereof | |
| AU2018904117 | 2018-10-30 | ||
| AU2019903255 | 2019-09-04 | ||
| AU2019903255A AU2019903255A0 (en) | 2019-09-04 | Polypeptides and uses thereof | |
| PCT/AU2019/051189 WO2020087116A1 (en) | 2018-10-30 | 2019-10-29 | Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025072427A Division JP2025129148A (ja) | 2018-10-30 | 2025-04-24 | Ｃａｒを発現する免疫細胞に抗原提示細胞を係合させるための二重特異性ポリペプチド及びそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022528024A JP2022528024A (ja) | 2022-06-08 |
| JP2022528024A5 true JP2022528024A5 (https=) | 2022-11-10 |
| JP7674243B2 JP7674243B2 (ja) | 2025-05-09 |
Family
ID=70461795
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525181A Active JP7674243B2 (ja) | 2018-10-30 | 2019-10-29 | Ｃａｒを発現する免疫細胞に抗原提示細胞を係合させるための二重特異性ポリペプチド及びそれらの使用 |
| JP2025072427A Pending JP2025129148A (ja) | 2018-10-30 | 2025-04-24 | Ｃａｒを発現する免疫細胞に抗原提示細胞を係合させるための二重特異性ポリペプチド及びそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025072427A Pending JP2025129148A (ja) | 2018-10-30 | 2025-04-24 | Ｃａｒを発現する免疫細胞に抗原提示細胞を係合させるための二重特異性ポリペプチド及びそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11866504B2 (https=) |
| EP (1) | EP3877417A4 (https=) |
| JP (2) | JP7674243B2 (https=) |
| CN (1) | CN113195535A (https=) |
| AU (2) | AU2019370618C1 (https=) |
| CA (1) | CA3117079A1 (https=) |
| SG (1) | SG11202104180WA (https=) |
| WO (1) | WO2020087116A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7846667B2 (ja) | 2020-07-16 | 2026-04-15 | レジェンド バイオテック アイルランド リミテッド | Ｃｄ２０結合分子及びその使用 |
| IL299865A (en) * | 2020-07-16 | 2023-03-01 | Nanjing Legend Biotech Co Ltd | Multispecific chimeric antigen receptors and uses thereof |
| AU2023347073A1 (en) * | 2022-09-20 | 2025-01-02 | Currus Biologics Pty Ltd | Anti-flag antibodies |
| KR20250071228A (ko) * | 2022-09-20 | 2025-05-21 | 커러스 바이오로직스 피티와이 엘티디 | 고갈된 면역 세포를 구제하는 방법 |
| AU2023347072A1 (en) * | 2022-09-20 | 2025-01-02 | Currus Biologics Pty Ltd | Bispecific polypeptides and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2990416B1 (en) * | 2014-08-29 | 2018-06-20 | GEMoaB Monoclonals GmbH | Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders |
| CN104829730A (zh) * | 2015-04-14 | 2015-08-12 | 苏静 | 一种能联合免疫细胞增强肿瘤杀伤能力的双特异性抗体及其制备方法和应用 |
| EP3295171A1 (en) * | 2015-05-12 | 2018-03-21 | INSERM - Institut National de la Santé et de la Recherche Médicale | Methods and kits for labeling, detection and isolation of foxp3+ regulatory t cells, isolated population of foxp3+ regulatory t cells thus obtained and uses thereof |
| WO2017167350A1 (en) * | 2016-03-30 | 2017-10-05 | Horst Lindhofer | Multispecific antibodies for use in the treatment of a neoplasm of the urinary tract |
| CA3021634A1 (en) * | 2016-04-15 | 2017-10-19 | Zymeworks Inc. | Multi-specific antigen-binding constructs targeting immunotherapeutics |
| CN107417792B (zh) * | 2017-08-29 | 2020-07-03 | 天津医科大学总医院 | 抗cd40-her2双特异性单链抗体及其在制备抗肿瘤药物中的应用 |
| CN113286811B (zh) * | 2018-07-30 | 2024-12-06 | 南加利福尼亚大学 | 改善过继性细胞疗法的效力和安全性 |
-
2019
- 2019-10-29 SG SG11202104180WA patent/SG11202104180WA/en unknown
- 2019-10-29 AU AU2019370618A patent/AU2019370618C1/en active Active
- 2019-10-29 JP JP2021525181A patent/JP7674243B2/ja active Active
- 2019-10-29 CN CN201980075175.XA patent/CN113195535A/zh active Pending
- 2019-10-29 CA CA3117079A patent/CA3117079A1/en active Pending
- 2019-10-29 EP EP19879319.2A patent/EP3877417A4/en active Pending
- 2019-10-29 WO PCT/AU2019/051189 patent/WO2020087116A1/en not_active Ceased
- 2019-10-29 US US17/289,997 patent/US11866504B2/en active Active
-
2022
- 2022-11-04 AU AU2022263573A patent/AU2022263573B2/en active Active
-
2023
- 2023-11-13 US US18/507,157 patent/US20240150482A1/en active Pending
-
2025
- 2025-04-24 JP JP2025072427A patent/JP2025129148A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022528024A5 (https=) | ||
| Iwahori | Cytotoxic CD8+ lymphocytes in the tumor microenvironment | |
| US20240325450A1 (en) | Nkt-cell subset for in vivo persistence and therapeutic activity and propagation of same | |
| Yu et al. | Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma | |
| CA3162930A1 (en) | Recombinant polypeptides for programming extracellular vesicles | |
| JP2021523110A (ja) | 遺伝子発現のためのナノ粒子及びその使用 | |
| JP2023505206A5 (https=) | ||
| US12491201B2 (en) | Maximizing T-cell memory and compositions and methods therefor | |
| JP2018509163A5 (https=) | ||
| JP2024515319A5 (https=) | ||
| Ghorashian et al. | CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor | |
| EP4242309A1 (en) | Chimeric antigen receptor | |
| JP2023503840A5 (https=) | ||
| Bozorgi et al. | Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects | |
| Stefanidis et al. | Combining SiRPα decoy–coengineered T cells and antibodies augments macrophage-mediated phagocytosis of tumor cells | |
| Jiang et al. | Combination of vaccination and chimeric receptor expressing T cells provides improved active therapy of tumors | |
| CN120676960A (zh) | 开发增强car t细胞的功能和/或持久性的car衔接分子平台 | |
| Fujii et al. | NKT-Licensed In Vivo Dendritic Cell− Based Immunotherapy as Cellular Immunodrugs for Cancer Treatment | |
| Kucharczyk et al. | Adoptive T-cell therapy in sarcomas | |
| UNG NHAT MINH | Significance of cd28 and 41bb costimulatory endodomains in short-and long-term activation of her2-specific car t cells | |
| HK40090148A (zh) | 用於得到体内存留性和治疗活性的nkt细胞亚群以及其繁殖 | |
| HK40117726A (en) | Nkt-cell subset for in vivo persistence and therapeutic activity and propagation of same | |
| HK40089233A (zh) | 表达嵌合抗原受体的修饰单核细胞/巨噬细胞及其用途 | |
| Pollack et al. | Cellular Immunotherapy for Sarcomas | |
| Provides | Combination of Vaccination and Chimeric |